Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
The International Journal of Cardiovascular Imaging
Published in: The International Journal of Cardiovascular Imaging 2/2011

01-02-2011 | Original Paper

Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities

Authors: Salvatore Brugaletta, Jose Ribamar Costa Jr, Hector M. Garcia-Garcia

Published in: The International Journal of Cardiovascular Imaging | Issue 2/2011

Login to get access

Abstract

Grayscale IVUS and IVUS-based imaging modalities during the last years have become useful in the assessment not only of drug eluting stent, but also of new bioresorbable vascular scaffolds. Although IVUS resolution is not sufficient for determining stent coverage (optical coherence tomography is the gold standard), serial IVUS can measure intimal hyperplasia, assess acute and late incomplete stent apposition, detect the presence and persistence of edge dissections, study edge effects and look for causes of restenosis and thrombosis. In addition other IVUS-based imaging modalities, such as IVUS-VH, iMAP or palpography, can be used to study the serial compositional and mechanical changes of the plaque behind stent struts and also to follow the bioresorption of the new bioresorbable scaffolds, analyzing the backscattering signal coming from the polymeric struts. This review details and evaluates grayscale IVUS and IVUS-based techniques findings in clinical trials, highlighting the usefulness of these imaging modalities in the study of drug eluting stents and bioresorbable vascular scaffold.
Literature
1.
Das P, Meredith I (2007) Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev Cardiovasc Ther 5:81–89PubMedCrossRef
2.
Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention–summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113:156–75
3.
Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG (2002) Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106:2200–2206PubMedCrossRef
4.
Nair A, Margolis MP, Kuban BD, Vince DG (2007) Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention 3:113–120PubMed
5.
Ramcharitar S, Garcia-Garcia HM, Nakazawa G et al (2007) Ultrasonic and pathological evidence of a neo-intimal plaque rupture in patients with bare metal stents. EuroIntervention 3:290–291PubMedCrossRef
6.
Kubo T, Maehara A, Mintz GS et al (2010) Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound. Am Heart J 159:271–277PubMedCrossRef
7.
Garcia-Garcia HM, Gonzalo N, Pawar R et al (2009) Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 4:443–448PubMedCrossRef
8.
Sarno G, Onuma Y, Garcia HM et al (2010) IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process. Catheter Cardiovasc Interv 75:914–918PubMed
9.
Mintz GS (2007) Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 100:26M–35MPubMedCrossRef
10.
Moses JW, Dangas G, Mehran R, Mintz GS (2008) Drug-eluting stents in the real world: how intravascular ultrasound can improve clinical outcome. Am J Cardiol 102:24J–28JPubMedCrossRef
11.
Roy P, Steinberg DH, Sushinsky SJ et al (2008) The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29:1851–1857PubMedCrossRef
12.
Costa MA, Angiolillo DJ, Tannenbaum M et al (2008) Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 101:1704–1711PubMedCrossRef
13.
de Jaegere P, Mudra H, Figulla H et al (1998) Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the multicenter ultrasound stenting in coronaries study (MUSIC Study). Eur Heart J 19:1214–1223PubMedCrossRef
14.
Fujii K, Carlier SG, Mintz GS et al (2005) Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45:995–998PubMedCrossRef
15.
Okabe T, Mintz GS, Buch AN et al (2007) Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 100:615–620PubMedCrossRef
16.
Sonoda S, Morino Y, Ako J et al (2004) Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 43:1959–1963PubMedCrossRef
17.
Hong MK, Mintz GS, Lee CW et al (2006) Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27:1305–1310PubMedCrossRef
18.
Sakurai R, Ako J, Morino Y et al (2005) Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 96:1251–1253PubMedCrossRef
19.
Wentzel JJ, Gijsen FJ, Stergiopulos N, Serruys PW, Slager CJ, Krams R (2003) Shear stress, vascular remodeling and neointimal formation. J Biomech 36:681–688PubMedCrossRef
20.
Serruys PW, Degertekin M, Tanabe K et al (2004) Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 109:627–633PubMedCrossRef
21.
Weissman NJ, Koglin J, Cox DA et al (2005) Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 45:1201–1205PubMedCrossRef
22.
Sakurai R, Hongo Y, Yamasaki M et al (2007) Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 100:818–823PubMedCrossRef
23.
Aoki J, Colombo A, Dudek D et al (2005) Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112:3876–3883PubMedCrossRef
24.
Tanabe K, Serruys PW, Degertekin M et al (2005) Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 111:900–905PubMedCrossRef
25.
Ako J, Morino Y, Honda Y et al (2005) Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 46:1002–1005PubMedCrossRef
26.
Kimura M, Mintz GS, Carlier S et al (2006) Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 98:436–442PubMedCrossRef
27.
Hong MK, Mintz GS, Lee CW et al (2006) Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113:414–419PubMedCrossRef
28.
Serruys PW, Ruygrok P, Neuzner J et al (2006) A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial. EuroIntervention 2:286–294PubMed
29.
Escolar E, Mintz GS, Popma J et al (2007) Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol 100:621–626PubMedCrossRef
30.
Cook S, Wenaweser P, Togni M et al (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115:2426–2434PubMedCrossRef
31.
de Ribamar Costa J, Mintz GS Jr, Carlier SG Jr et al (2007) Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 153:297–303PubMedCrossRef
32.
Shaikh F, Maddikunta R, Djelmami-Hani M, Solis J, Allaqaband S, Bajwa T (2008) Stent fracture, an incidental finding or a significant marker of clinical in-stent restenosis? Catheter Cardiovasc Interv 71:614–618PubMedCrossRef
33.
Yamada KP, Koizumi T, Yamaguchi H et al (2008) Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. Int J Cardiol 130:255–259PubMedCrossRef
34.
Doi H, Maehara A, Mintz GS et al (2009) Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol 103:818–823PubMedCrossRef
35.
Farb A, Kolodgie FD, Hwang JY et al (2004) Extracellular matrix changes in stented human coronary arteries. Circulation 110:940–947PubMedCrossRef
36.
Finn AV, Nakazawa G, Joner M et al (2007) Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27:1500–1510PubMedCrossRef
37.
Nasu K, Tsuchikane E, Katoh O et al (2006) Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol 47:2405–2412PubMedCrossRef
38.
Farb A, Burke AP, Kolodgie FD, Virmani R (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108:1701–1706PubMedCrossRef
39.
MP NairA, Kuban BD, Vince DG (2007) Automated coronary plaque characterization with intravascular ultrasound backscatter: ex vivo validation. Eurointervention 3:113–130
40.
Garcia-Garcia HM, Goedhart D, Serruys PW (2007) Relation of plaque size to necrotic core in the three major coronary arteries in patients with acute coronary syndrome as determined by intravascular ultrasonic imaging radiofrequency. Am J Cardiol 99:790–792PubMedCrossRef
41.
Ramcharitar S, Gonzalo N, van Geuns RJ et al (2009) First case of stenting of a vulnerable plaque in the SECRITT I trial-the dawn of a new era? Nat Rev Cardiol 6:374–378PubMedCrossRef
42.
Kim SW, Mintz GS, Hong YJ et al (2008) The virtual histology intravascular ultrasound appearance of newly placed drug-eluting stents. Am J Cardiol 102:1182–1186PubMedCrossRef
43.
Serruys PW, Ormiston JA, Onuma Y et al (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897–910PubMedCrossRef
44.
Ormiston JA, Serruys PW, Regar E et al (2008) A bioabsorbable everolimus-eluting coronary stent system for patients with single de novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 371:899–907PubMedCrossRef
45.
Aoki J, Abizaid AC, Serruys PW et al (2005) Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46:1670–1676PubMedCrossRef
46.
Garcia-Garcia HM, Gonzalo N, Tanimoto S, Meliga E, de Jaegere P, Serruys PW (2008) Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. Rev Esp Cardiol 61:1013–1019PubMed
47.
Sathyanarayana S, Carlier S, Li W, Thomas L (2009) Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention 5:133–139PubMedCrossRef
48.
Shin ES, Garcia Garcia HM, Lighthart J, et al (2010) In Vivo Findings of Tissue Characteristics using iMap™ IVUS and Virtual Histology™ IVUS EuroInterv In press 2010
49.
de Korte CL, Sierevogel MJ, Mastik F et al (2002) Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 105:1627–1630PubMedCrossRef
50.
Van Mieghem CA, McFadden EP, de Feyter PJ et al (2006) Noninvasive detection of subclinical coronary atherosclerosis coupled with assessment of changes in plaque characteristics using novel invasive imaging modalities: the Integrated Biomarker and Imaging Study (IBIS). J Am Coll Cardiol 47:1134–1142PubMedCrossRef
51.
Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI (2009) Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv 2:1035–1046PubMedCrossRef
52.
Bouma BE, Tearney GJ, Yabushita H et al (2003) Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart 89:317–320PubMedCrossRef
Metadata
Title
Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities
Authors
Salvatore Brugaletta
Jose Ribamar Costa Jr
Hector M. Garcia-Garcia
Publication date
01-02-2011
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 2/2011
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9788-8

Other articles of this Issue 2/2011

The International Journal of Cardiovascular Imaging 2/2011 Go to the issue

Original Paper

Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond

Original Paper

Fusion of 3D QCA and IVUS/OCT

Original Paper

Dedicated bifurcation analysis: basic principles

Original Paper

Bifurcation lesion morphology and intravascular ultrasound assessment

Original Paper

Novel QCA methodologies and angiographic scores

Original Paper

Dedicated bifurcation analysis: dedicated devices